Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Folic Acid and Creatine as Therapeutic Approaches for Lowering Blood Arsenic (FACTA)

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Mary Gamble, Columbia University
ClinicalTrials.gov Identifier:
NCT01050556
First received: January 13, 2010
Last updated: July 31, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2011
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)